J M Bozarth - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J M Bozarth

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998

Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3S A Mousa, J M Bozarth, W Lorelli, et al.

Biochemical and Biophysical Research Communications|September 30, 1991

Inhibition of the thrombin-platelet reactions by DuP 714A T Chiu, S A Mousa, L J Pease, et al.

Cardiology|January 1, 1993

Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonistS A Mousa, J M Bozarth, M S Forsythe, et al.

Biopharmaceutics & Drug Disposition|March 4, 2000

Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pigJ S Barrett, J Yu, R Kapil, et al.

Circulation|January 1, 1994

Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonistS A Mousa, J M Bozarth, M S Forsythe, et al.

Journal of Cardiovascular Pharmacology|August 13, 1998

Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998

Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3S A Mousa, J M Bozarth, W Lorelli, et al.

Biochemical and Biophysical Research Communications|September 30, 1991

Inhibition of the thrombin-platelet reactions by DuP 714A T Chiu, S A Mousa, L J Pease, et al.

Cardiology|January 1, 1993

Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonistS A Mousa, J M Bozarth, M S Forsythe, et al.

Biopharmaceutics & Drug Disposition|March 4, 2000

Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pigJ S Barrett, J Yu, R Kapil, et al.

Circulation|January 1, 1994

Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonistS A Mousa, J M Bozarth, M S Forsythe, et al.

Journal of Cardiovascular Pharmacology|August 13, 1998

Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.

Pageof 2